Literature DB >> 22103450

Perceptions of Caribbean type 2 diabetes patients on self-monitoring of blood glucose.

C E Ezenwaka1, A Olukoga, P Onuoha, R Worrell, T Skinner, H Mayers, E Martin, C Phillip.   

Abstract

CONTEXT: The views of type 2 diabetes (T2DM) patients have not been considered in the debate on the role of self-monitoring of blood glucose (SMBG) in the management of T2DM.
OBJECTIVE: To assess the views of T2DM patients on SMBG.
METHODS: Two previously trained research assistants used a structured pre-tested questionnaire to interview 416 T2DM patients practising SMBG in out-patient clinics in the privacy of the patients after they have consented to be interviewed.
RESULTS: 79% of patients were unemployed with mean duration of diabetes of 11.8 ± 0.5 year. 94% of patients did not have health insurance policies while 86% did not belong to any diabetes support group. Although 70% of the patients identified SMBG as expensive, 94% believed it assists glycaemic control, while 89% thought it was worth the expense.
CONCLUSION: Caribbean T2DM patients believe SMBG was beneficial for the management of their diabetes and empowering them may reduce diabetes complications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22103450     DOI: 10.3109/13813455.2011.625950

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  2 in total

1.  Self-monitoring of blood glucose in Black Caribbean and South Asian Canadians with non-insulin treated Type 2 diabetes mellitus: a qualitative study of patients' perspectives.

Authors:  Enza Gucciardi; Mariella Fortugno; Andrea Senchuk; Heather Beanlands; Elizabeth McCay; Elizabeth E Peel
Journal:  BMC Endocr Disord       Date:  2013-10-14       Impact factor: 2.763

2.  Impact of self-funding on patient experience of oral anticoagulation self-monitoring: a qualitative study.

Authors:  Alice Tompson; Carl Heneghan; Stephen Sutton; David Fitzmaurice; Alison Ward
Journal:  BMJ Open       Date:  2016-12-23       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.